Review Supports Dexrazoxane Use for Cardioprotection

The practice of giving dexrazoxane to protect the hearts of pediatric patients receiving anthracycline chemotherapy is supported by a review published in the British Journal of Clinical Pharmacology.

Read more here: http://www.clinicaloncology.com/Current-Practice/Article/11-16/Review-Supports-Dexrazoxane-Use-for-Cardioprotection/38474